Can gene expression profiling of PBMCs during early STEMI predict the development of heart failure?
Gene expression profiling of PBMCs during early STEMI may provide prognostic biomarkers for predicting the subsequent development of heart failure.
This study demonstrates an altered gene expression profile in PBMCs during acute myocardial infarction and through the follow-up. The identified gene expression changes at the early phase of STEMI that differentiated the patients who developed HF from those who did not could serve as a convenient tool contributing to the prognosis of heart failure.
Maciejak et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: